to block the substances ( proteins ) that lead to that growth , which include vascular endothelial growth factor ( VEGF ) and placental growth factor(passive) are designedAngiogenesis inhibitors

Dr. Folkman and his colleaguesdiscoveredangiogenesis inhibitors

from a variety of sources(passive) have been discoveredAngiogenesis inhibitors

to prevent the formation of new blood vessels(passive) are designedAngiogenesis inhibitors

to stop tumours growing by cutting off their blood supply(passive) are designedAngiogenesis inhibitors

based on the structural data for AIDS therapy(passive) were successfully designedProtease inhibitors

to limit the effects of a cell structure called a proteasome(passive) are designedProteasome inhibitors

also(passive) are ... influencedTrypsin inhibitors

to mimic the transition state of the protease 's actual substrates(passive) were designedProtease inhibitors

the drug(passive) were discoveredProtease inhibitors

to target(passive) were designedprotease inhibitors

from natural sources , including : tree bark , fungi , shark muscle and cartilage , sea coral , green tea and herbs(passive) have been discoveredAngiogenesis inhibitors

The workleadingto protease inhibitors

Our groupis discoveringprotease inhibitors

biopharmaceutical researchersdiscoveredprotease inhibitors

first(passive) were ... inventedprotease inhibitors

functionalized peptide moleculesdesignedas protease inhibitors

to do not meanresultsfrom protease inhibitors

to block certain enzymes the virus needs to replicate(passive) are designedProtease inhibitors

Coadministration of desloratadine withresultsCYP3A4 inhibitors

Baker ... blood and cholesterol imbalancesresultfrom protease inhibitors

Deaths from HIV / AIDS , which was relatively unknown in 1980 ... biopharmaceutical researchersdiscoveredprotease inhibitors

drugsmay ... causereuptake inhibitors

to regulate glucose by manipulating a protein found in the renal system(passive) are designedSGLT2 inhibitors

The combination of Adderall and selective serotoninresultsreuptake inhibitors

to inhibit renal glucose reabsorption with the goal of lowering blood glucose(passive) are designedSGLT2 inhibitors

to control diabetes by blocking reabsorption(passive) are designedSGLT2 inhibitors

e. Early attempts , dating deny to the late sto discoverCOMT inhibitors

a targeted programto discoverPARG inhibitors

to keep the protein from performing its function(passive) are designedSGLT2 inhibitors

to control diabetes by blocking reabsorption of glucose by the kidneys , impacting normal kidney function and allowing more sugar to be passed from the body through urine(passive) are designedSGLT2 inhibitors

from natural sources , including tree bark , fungi , shark muscle and cartilage , sea coral , green tea and herbs ( licorice , ginseng , cumin , garlic(passive) have been discovered Angiogenesis inhibitors

from natural sources , including tree bark , fungi , shark muscle and cartilage , sea coral , green tea , and herbs ( licorice , ginseng , cumin , garlic(passive) have been discoveredAngiogenesis inhibitors

with the aim of developing analgesic and antihypertensive agents that act by preventing neprilysin 's activity against signaling peptides such as enkephalins , substance P , endothelin , and atrial natriuretic peptide(passive) have been designedInhibitors Inhibitors

to disrupt the function of the Wee1 protein kinase ( which helps to regulate the cell cycle ) and to cause tumor cells to divide without undergoing the normal DNA repair process , ultimately leading to tumor cell death(passive) are designedWee1 inhibitors